Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Impact of natural menopause on multiple sclerosis: a multicentre study.

Baroncini D, Annovazzi PO, De Rossi N, Mallucci G, Torri Clerici V, Tonietti S, Mantero V, Ferrò MT, Messina MJ, Barcella V, La Mantia L, Ronzoni M, Barrilà C, Clerici R, Susani EL, Fusco ML, Chiveri L, Abate L, Ferraro O, Capra R, Colombo E, Confalonieri P, Zaffaroni M.

J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1201-1206. doi: 10.1136/jnnp-2019-320587. Epub 2019 Jun 12.

PMID:
31189614
2.

Four cases of natalizumab-related PML: a less severe course in extended interval dosing?

Scarpazza C, De Rossi N, Tabiadon G, Turrini MV, Gerevini S, Capra R.

Neurol Sci. 2019 Oct;40(10):2119-2124. doi: 10.1007/s10072-019-03959-4. Epub 2019 Jun 7.

PMID:
31175467
3.

Dealing with highly active multiple sclerosis after natalizumab-associated PML: could rituximab be of help?

Mancinelli CR, Scarpazza C, Santuccio G, De Rossi N, Capra R.

Neurol Sci. 2018 May;39(5):965-966. doi: 10.1007/s10072-017-3228-7. Epub 2018 Jan 4. No abstract available.

PMID:
29302813
4.

Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.

Mariotto S, Ferrari S, Monaco S, Benedetti MD, Schanda K, Alberti D, Farinazzo A, Capra R, Mancinelli C, De Rossi N, Bombardi R, Zuliani L, Zoccarato M, Tanel R, Bonora A, Turatti M, Calabrese M, Polo A, Pavone A, Grazian L, Sechi G, Sechi E, Urso D, Delogu R, Janes F, Deotto L, Cadaldini M, Bianchi MR, Cantalupo G, Reindl M, Gajofatto A.

J Neurol. 2017 Dec;264(12):2420-2430. doi: 10.1007/s00415-017-8635-4. Epub 2017 Oct 23.

5.

To do or not to do? plasma exchange and timing of steroid administration in progressive multifocal leukoencephalopathy.

Scarpazza C, Prosperini L, De Rossi N, Moiola L, Sormani MP, Gerevini S, Capra R; Italian PML group.

Ann Neurol. 2017 Nov;82(5):697-705. doi: 10.1002/ana.25070. Epub 2017 Oct 31.

PMID:
29023856
6.

Corrigendum to "Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?" [J. Neurol. Sci. 378 (2017) 233-237].

Scarpazza C, Prosperini L, Mancinelli CR, De Rossi N, Lugaresi A, Capobianco M, Moiola L, Naldi P, Imberti L, Gerevini S, Capra R.

J Neurol Sci. 2017 Sep 15;380:19. doi: 10.1016/j.jns.2017.06.037. Epub 2017 Jul 4. No abstract available.

PMID:
28870565
7.

Association Between BKPyV Serotype I Antibody Level and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.

Rossi F, Prosperini L, De Rossi N, Capra R, Rivanera D, Li X, Cinque P, Passeri L, Pozzilli C, Viscidi R.

Viral Immunol. 2017 Oct;30(8):622-626. doi: 10.1089/vim.2017.0039. Epub 2017 Aug 24.

PMID:
28836899
8.

Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy.

Prosperini L, Scarpazza C, Imberti L, Cordioli C, De Rossi N, Capra R.

J Neurovirol. 2017 Oct;23(5):742-749. doi: 10.1007/s13365-017-0561-9. Epub 2017 Aug 8.

PMID:
28791614
9.

Patient and doctor perspectives on HIV screening in the emergency department: A prospective cross-sectional study.

De Rossi N, Dattner N, Cavassini M, Peters S, Hugli O, Darling KEA.

PLoS One. 2017 Jul 21;12(7):e0180389. doi: 10.1371/journal.pone.0180389. eCollection 2017.

10.

Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?

Scarpazza C, Prosperini L, Mancinelli CR, De Rossi N, Lugaresi A, Capobianco M, Moiola L, Naldi P, Imberti L, Gerevini S, Capra R.

J Neurol Sci. 2017 Jul 15;378:233-237. doi: 10.1016/j.jns.2017.05.018. Epub 2017 May 12. Erratum in: J Neurol Sci. 2017 Sep 15;380:19.

PMID:
28566170
11.

No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML.

Landi D, De Rossi N, Zagaglia S, Scarpazza C, Prosperini L, Albanese M, Buttari F, Mori F, Marfia GA, Sormani MP, Capra R, Centonze D; Italian PML study group.

Neurology. 2017 Mar 21;88(12):1144-1152. doi: 10.1212/WNL.0000000000003740. Epub 2017 Feb 22.

12.

Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry.

Prosperini L, de Rossi N, Scarpazza C, Moiola L, Cosottini M, Gerevini S, Capra R; Italian PML study group.

PLoS One. 2016 Dec 20;11(12):e0168376. doi: 10.1371/journal.pone.0168376. eCollection 2016.

13.

Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.

Diotti RA, Capra R, Moiola L, Caputo V, De Rossi N, Sangalli F, Martinelli V, Burioni R, Clementi M, Mancini N.

Viruses. 2016 May 7;8(5). pii: E128. doi: 10.3390/v8050128.

14.

Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients.

Cordioli C, De Rossi N, Rasia S, Lodoli G, Capra R.

Neurol Sci. 2015 Mar;36(3):489-91. doi: 10.1007/s10072-014-1918-y. Epub 2014 Aug 11. No abstract available.

PMID:
25109815
15.

Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.

Ghezzi A, Annovazzi P, Cocco E, Coarelli G, Lugaresi A, Rovaris M, Patti F, Capello E, Rodegher ME, Moiola L, Malucchi S, Salemi G, De Rossi N, Provinciali L, Perini P, Bergamaschi R, Scarpini E, Lus G, Gallo A, Tola MR, Amato MP, Rottoli MR, Bianchi A, Comi G; MS Study Group-Italian Society of Neurology.

Neurol Sci. 2013 Sep;34(9):1633-7. doi: 10.1007/s10072-013-1300-5. Epub 2013 Jan 25.

PMID:
23354606
16.

Peritoneography and peritoneal computerized tomography: a new approach to non-infectious complications of CAPD.

Scanziani R, Dozio B, Caimi F, De Rossi N, Magri F, Surian M.

Nephrol Dial Transplant. 1992;7(10):1035-8.

PMID:
1331880

Supplemental Content

Loading ...
Support Center